NCT00252733View on ClinicalTrials.gov

Diabetic Retinopathy Candesartan Trials

PHASE3CompletedINTERVENTIONAL

Enrollment

5,238

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions

Type 1 Diabetes

Interventions

DRUG

candesartan cilexetil

32 mg once daily oral tablet given over 60 months

Trial Locations (3)

Unknown

Research Site, Herston

Research Site, Perth

Research Site, Odense

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

Takeda

INDUSTRY

lead

AstraZeneca

INDUSTRY